Aurobindo Pharma recalls 1.5g Ampicillin and Sulbactam injections due to glass particles found in vials. Affected units have NDC 55150-116-20 and lot AF0117001-A. Stop using immediately if you have these products.
Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.
“Aurobindo Ampicillin/Sulbactam Injections Recall: Visible Glass Particulates.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40958-aurobindo-ampicillin-sulbactam-injections-recall-visible-glass-particulates. Based on FDA recall #D-0339-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0339-2018%22&limit=1).
The FDA announced on Jan. 2, 2018, that Aurobindo Pharma Ltd. voluntarily recalled Ampicillin and Sulbactam for Injection due to the presence of glass particulate matter in a single vial. The recall affects 53,040 vials distributed nationwide.
How to tell if you have it
Brand: Aurobindo Pharma Ltd.
Product: Ampicillin and Sulbactam for Injection 1.5 g vial
NDC: 55150-116-20
Lot Number: AF0117001-A
The hazard
A confirmed customer report identified visible particulate matter, confirmed as glass, within a single vial of the sterile Dry Powder for injection. The recall is classified as Class I.
Context
GovInfoNow's records show Aurobindo Pharma Ltd. has two other recalls on record since March 9, 2012, including a Feb. 2, 2018, recall of Metformin 1000mg for foreign tablet hazards and a March 9, 2012, recall of Northstar Zolpidem for adulterated foreign tablets. Other recent recalls of similar products include Sun Pharmaceutical DOXOrubin Liposome Injection (May 12, 2026), Imprimis Dexamethasone Moxifloxacin Eye Drops (Dec. 18, 2025), and American Regent Papaverine HCl Injection (July 24, 2026).
How to tell if you have this one
Check for vials labeled 'Ampicillin and Sulbactam for Injection 1.5 g' with NDC 55150-116-20 and lot number AF0117001-A. The product comes in 10 vials per carton.
Brand
Aurobind: Aurobindo Pharma Ltd.
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
Discard the vials if you have the recalled product with NDC 55150-116-20 and lot AF0117001-A.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “distributed nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0339-2018 (January 2, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0339-2018 to see it in context.
Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.